Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 8,800 | 1,900 | -700 | N/A |
| Depreciation Amortization | N/A | 54,600 | 36,300 | 18,300 | N/A |
| Income taxes - deferred | N/A | 3,000 | 2,300 | 2,700 | N/A |
| Accounts receivable | N/A | -27,000 | -900 | -3,300 | N/A |
| Accounts payable and accrued liabilities | N/A | -8,100 | -300 | -8,400 | N/A |
| Other Working Capital | N/A | -28,100 | -4,300 | -14,900 | N/A |
| Other Operating Activity | 0 | 49,000 | 10,600 | 14,100 | 0 |
| Operating Cash Flow | $N/A | $52,200 | $45,600 | $7,800 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -7,200 | -4,100 | -1,300 | N/A |
| Net Acquisitions | N/A | -278,500 | -278,500 | -279,600 | N/A |
| Purchase Of Investment | N/A | -57,000 | -36,600 | -14,400 | N/A |
| Sale Of Investment | N/A | 51,800 | 32,100 | 16,300 | N/A |
| Investing Cash Flow | $N/A | $-290,900 | $-287,100 | $-279,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 340,000 | 340,000 | 290,000 | N/A |
| Debt Repayment | N/A | -85,000 | -75,000 | -40,000 | N/A |
| Common Stock Issued | N/A | 6,500 | 4,500 | 2,100 | N/A |
| Common Stock Repurchased | N/A | -50,000 | -50,000 | N/A | N/A |
| Other Financing Activity | 0 | -1,400 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $210,100 | $219,500 | $252,100 | $N/A |
| Exchange Rate Effect | N/A | 2,600 | 1,700 | 1,500 | N/A |
| Beginning Cash Position | N/A | 110,900 | 110,900 | 110,900 | N/A |
| End Cash Position | N/A | 84,900 | 90,600 | 93,300 | N/A |
| Net Cash Flow | $N/A | $-26,000 | $-20,300 | $-17,600 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 52,200 | 45,600 | 7,800 | N/A |
| Capital Expenditure | N/A | -7,200 | -4,100 | -1,300 | N/A |
| Free Cash Flow | 0 | 45,000 | 41,500 | 6,500 | 0 |